ITCI US46116X1019

Report

Delayed Nasdaq - 04:00:00 2023-02-03 pm EST
48.92	USD		-1.65%

01/13	RBC Cuts Price Target on Intra-Cellular Therapies to $72 From $74, Maintains Outperform Rating	MT
01/09	Intra-cellular Therapies, Inc. : Entry into a Material Definitive Agreement (form 8-K)	AQ
01/09	Transcript : Intra-Cellular Therapies, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 11:15 AM	CI

Calendar

Event chart INTRA-CELLULAR THERAPIES, INC.

Upcoming events on INTRA-CELLULAR THERAPIES, INC.

03/01/23		FY 2022 Earnings Release (Projected)
05/10/23		Q1 2023 Earnings Release (Projected)
08/09/23		Interim 2023 Earnings Release (Projected)
11/08/23		Q3 2023 Earnings Release (Projected)

Past events on INTRA-CELLULAR THERAPIES, INC.

01/09/23 \| 02:15pm		JP Morgan Healthcare Conference
11/29/22 \| 12:35pm		Evercore ISI HealthCONx Conference
11/14/22		J.P. Morgan Equity Opportunities Forum
11/03/22 \| 07:30am		Q3 2022 Earnings Call
11/03/22 \| 06:30am		Q3 2022 Earnings Release
08/09/22 \| 08:30am		Interim 2022 Earnings Call
08/09/22 \| 07:30am		Interim 2022 Earnings Release
06/11/22		International Society for Bipolar Disorders Conference - Lumateperone
06/11/22		International Society for Bipolar Disorders Conference - Effect of Lumateperone
06/11/22		International Society for Bipolar Disorders Conference - Metabolic Syndrome

Past dividends on INTRA-CELLULAR THERAPIES, INC.

- No events available -

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread	0,25 0,27 -8,4%		0,06	22,8 22,3 2,5%	83,8 83,1 0,84%	249
Operating income (EBITDA) M $	Released Forecast Spread	-103 -102 -1,00%	-162 -174 7,0%	-154 -155 0,68%	-231 -240 4,0%	-285 -284 -0,44%	-276
Operating profit (EBIT) M $	Released Forecast Spread	-103 -98,5 -4,4%	-162 -170 4,8%	-154 -159 3,3%	-231 -237 2,6%	-286 -282 -1,3%	-274
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-98,8 -96,8 -2,1%	-155 -165 6,0%	-148 -152 2,7%	-227 -236 3,8%	-284 -282 -0,70%	-272
Net income M $	Released Forecast Spread	-97,8 -94,3 -3,6%	-155 -164 5,6%	-148 -151 2,5%	-227 -234 2,9%	-284 -282 -0,74%	-270
EPS $	Released Forecast Spread	-2,12 -2,07 -2,3%	-2,84 -3,00 5,4%	-2,68 -2,74 2,3%	-3,23 -3,34 3,3%	-3,50 -3,45 -1,3%	-2,87
Announcement Date		03/01/2018	02/27/2019	03/02/2020	02/25/2021	03/01/2022	-

Quarterly results

Fiscal Period : December

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q3

2022 Q4

Sales
M $

Released
Forecast
Spread

22,2
22,1
0,42%

25,7
25,0
2,6%

35,0
33,5
4,4%

55,6
48,6
14%

71,9
66,0
8,9%

87,0

Operating income
(EBITDA)
M $

Released
Forecast
Spread

-77,1
-77,8
0,87%

-85,9
-87,8
2,2%

-72,5
-85,3
15%

-87,8
-78,3
-12%

-55,5
-83,9
34%

-71,0

Operating profit
(EBIT)
M $

Released
Forecast
Spread

-77,3
-75,8
-2,0%

-86,0
-82,3
-4,5%

-72,7
-84,0
13%

-87,9
-70,7
-24%

-55,6
-77,3
28%

-57,3

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

-76,9
-72,7
-5,8%

-85,7
-83,8
-2,3%

-72,1
-88,7
19%

-86,6
-73,8
-17%

-53,5
-82,9
35%

-59,1

Net income
M $

Released
Forecast
Spread

-76,9
-74,7
-2,9%

-85,7
-83,4
-2,8%

-72,1
-85,8
16%

-86,6
-72,6
-19%

-53,5
-77,3
31%

-57,5

EPS
$

Released
Forecast
Spread

-0,95
-0,91
-3,8%

-1,05
-1,00
-4,6%

-0,78
-0,93
16%

-0,92
-0,77
-19%

-0,57
-0,82
31%

-0,60

Announcement Date

11/09/2021

03/01/2022

05/10/2022

08/09/2022

11/03/2022

Previous year

Next Year

Upcoming sector events for INTRA-CELLULAR THERAPIES, INC.

02/07/23		VERTEX PHARMACEUTICALS INCORPORATED : FY 2022 Earnings Release
03/21/23		WUXI APPTEC CO., LTD. : FY 2022 Earnings Release
03/29/23		BIONTECH SE : FY 2022 Earnings Release (Projected)
04/26/23		BEIGENE, LTD. : FY 2022 Earnings Release
05/02/23		WUXI APPTEC CO., LTD. : Q1 2023 Earnings Release (Projected)
05/03/23		VERTEX PHARMACEUTICALS INCORPORATED : Q1 2023 Earnings Release (Projected)
05/04/23		BEIGENE, LTD. : Q1 2023 Earnings Release (Projected)
05/04/23		REGENERON PHARMACEUTICALS, INC. : Q1 2023 Earnings Release (Projected)
05/08/23		BIONTECH SE : Q1 2023 Earnings Release (Projected)
08/03/23		VERTEX PHARMACEUTICALS INCORPORATED : Interim 2023 Earnings Release (Projected)

More events

Past sector events for INTRA-CELLULAR THERAPIES, INC.

02/03/23 \| 06:30am		REGENERON PHARMACEUTICALS, INC. : FY 2022 Earnings Release
11/09/22 \| 07:00am		BEIGENE, LTD. : Q3 2022 Earnings Release
11/07/22 \| 06:00am		BIONTECH SE : Q3 2022 Earnings Release
11/03/22 \| 05:30am		REGENERON PHARMACEUTICALS, INC. : Q3 2022 Earnings Release
10/27/22 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Q3 2022 Earnings Release
10/26/22		WUXI APPTEC CO., LTD. : Q3 2022 Earnings Release
08/26/22		BEIGENE, LTD. : Interim 2022 Earnings Release
08/08/22 \| 06:00am		BIONTECH SE : Interim 2022 Earnings Release
08/04/22 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release
08/03/22 \| 06:30am		REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release

More events

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise